Tortoside B (Manglieside E)

CAS No. 190655-17-5

Tortoside B (Manglieside E)( —— )

Catalog No. M32335 CAS No. 190655-17-5

Manglieside E significantly (p<0.05) increased the growth and differentiation of osteoblastic MC3T3-E1 cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 655 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tortoside B (Manglieside E)
  • Note
    Research use only, not for human use.
  • Brief Description
    Manglieside E significantly (p<0.05) increased the growth and differentiation of osteoblastic MC3T3-E1 cells.
  • Description
    Manglieside E significantly (p<0.05) increased the growth and differentiation of osteoblastic MC3T3-E1 cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    190655-17-5
  • Formula Weight
    582.6
  • Molecular Formula
    C28H38O13
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chem Pharm Bull (Tokyo) . 2008 Sep;56(9):1270-1275.
molnova catalog
related products
  • Apigenin 7-[rhamnosy...

    The leaves of Turpinia arguya Seem.

  • AZ876

    AZ876 is a potent highly selective LXR agonist with Ki/EC50 of 7/6 nM and 11/73 nM for hLXRα and hLXRβ respectively.

  • PF-04937319

    PF-04937319 is an activator of glucokinase (EC50 =154.4 ?μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus.